Bioinformatics &

Digital Health

Bioinformatics and Digital Health encompass many different fields of application. Continued advancements in bioinformatics are driving forward key developments in precision medicine, placing the patient at the heart of decisions.

We work with innovators in sequencing, genomics, proteomics, metabolomics and cell biology, as well as biosensors and artificial intelligence. We understand the challenges in this area, and can advise you on how to adapt your IP strategy to deal with these.

Our core bioinformatics team includes attorneys whose practice has a strong focus in this field, with backgrounds in bioinformatics/computational biology, biochemistry, electronics, physics and engineering. They form part of a wider multi-disciplinary team that is over 20-strong and made up of scientists and engineers who have deep knowledge and understanding of the variety of technologies and fields that bioinformatics touches.

We have our finger on the pulse of developments in EPO practice in relation to bioinformatics inventions. We have an impressive record of getting seemingly difficult cases through to grant. 

Digital Health innovations can give rise to a number of valuable assets from data to code, designs of user interfaces, new methods and know-how, each of which can be associated with multiple individual IP rights, both registered and unregistered. Our highly skilled legal team works seamlessly alongside our patent experts to help our clients build a strong bundle of IP rights, including copyrights, trade secrets, database rights, designs and patents. Our integrated team approach means that we can be with you all the way and across the whole spectrum of your IP needs, ensuring efficient, joined-up and commercially relevant advice.

Find out more on our Bioinformatics spotlight page.

Patent_Landscape_in_Bioinformatics_and_Digital_Health_Special_Report_2021-2-Compressed

Special Report

Patent Landscape in Bioinformatics and Digital Health: a data-driven analysis

The words "digital health", "data driven" and "AI" have been on everyone's lips and in many headlines in the healthcare and life sciences sectors over the last couple of years. However, navigating this rapidly changing landscape can be challenging for those in charge of managing the IP associated with the innovations underpinning these changes.  

In this Special Report, we set out to collect data on the patent landscape in the fields of bioinformatics and digital health, to see whether the growth we and our clients see in the field is reflected in the data and whether insights can be gained from the data that will assist in designing better, more informed IP strategies.

Read our blogs

Meet the team: Jeremy Webster, Partner, Head of Chemistry

Meet the team: Jeremy Webster, Partner, Head of Chemistry

by Jeremy Webster

As part of our 'meet the team' series, we talk to partner and head of chemistry, Jeremy Webster, about the importance of strong working relationships, taking a strategic approach to oppositions and ...

UPC Weekly - UPC Munich Central Division sets out a marker on how the UPC should approach inventive step

UPC Weekly - UPC Munich Central Division sets out a marker on how the UPC should approach inventive step

by Thomas Wolter

2024 Week 29 This week saw the first UPC decision on the merits issued in the long-running patent battle between Amgen and Sanofi/Regeneron. The decision is succinct and well-reasoned, featuring a ...

An emotional day - The Court of Appeal reverses the High Court’s earlier judgment

An emotional day - The Court of Appeal reverses the High Court’s earlier judgment

by Alex Burns

Today, the Court of Appeal handed down its hotly-anticipated judgment in the Emotional Perception AI case, the first case heard at this level on the patentability of AI-based inventions ...

National Paralegal Awards Finalists 2024

National Paralegal Awards Finalists 2024

by Lesley Gardner

We are extremely proud to announce our finalists in the National Paralegal Awards 2024 which promote the work and achievements of Paralegals in the UK.

Paw-some news for pets: UK’s first regulatory approval of cultivated meat

Paw-some news for pets: UK’s first regulatory approval of cultivated meat

by Louise Atkins

Lab-grown chicken from cultivated meat company Meatly has received regulatory approval in the UK.

EPO case law for antibodies – 2024 update

EPO case law for antibodies – 2024 update

by Rebecca Tollervey

In 2023 we published a pair of articles reviewing EPO case law in the field of antibodies, addressing questions of sufficiency of disclosure and inventive step. This article provides an update, a ...

Forward Magazines Overlapping 6-compressed

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.